Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Elevar Therapeutics

Clinical trials sponsored by Elevar Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill targets rare cancer gene in 30-Patient trial Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1 Terminated 1

Can a targeted drug shrink rare salivary gland tumors?

Disease control Stopped early

This phase 2 trial is testing the drug rivoceranib in adults with recurrent or metastatic adenoid cystic carcinoma, a rare cancer that often starts in the salivary glands. The study aims to see if the drug can shrink tumors or slow the disease. Participants take rivoceranib table…

Phase 2 • Sponsor: Elevar Therapeutics • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC